The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its mid-December bear gap, after which it hit a Jan. 17, 52-week low of $78.17 amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback